[{"edinetCode":"E33044","endDate":"2016\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":16.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":59612511.0,"sharesOwendPercent":0.7093,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2017\/3\/31","stockCode":4597,"accountingYear":"第９期（自　2016年１月１日　至　2016年12月31日）","accountingYearStart":"2016\/1\/1","accountingYearEnd":"2016\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2017\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":21.0,"averageTemporaryStaff":2.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":40605895.0,"sharesOwendPercent":0.4627,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/3\/30","stockCode":4597,"accountingYear":"第10期（自　2017年１月１日　至　2017年12月31日）","accountingYearStart":"2017\/1\/1","accountingYearEnd":"2017\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":31.0,"averageTemporaryStaff":1.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":34146154.0,"sharesOwendPercent":0.3251,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2019\/3\/29","stockCode":4597,"accountingYear":"第11期（自　2018年１月１日　至　2018年12月31日）","accountingYearStart":"2018\/1\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/15","stockCode":4597,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":33793517.0,"sharesOwendPercent":0.3204,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2019\/8\/14","stockCode":4597,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/13","stockCode":4597,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":52.0,"averageTemporaryStaff":1.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":44506670.0,"sharesOwendPercent":0.3809,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":7946000000.0,"currentAssets":4302000000.0,"fixedAsset":null,"tangibleFixedAssets":46000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":1029000000.0,"currentLiabilities":925000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":960000000.0,"capitalSurplus":4630000000.0,"accumulatedEarnings":1400000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":65000000.0,"grossProfit":null,"sgaExpenses":1868000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-828000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-735000000.0,"cashFlowFromFinancialActivities":1641000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2020\/3\/30","stockCode":4597,"accountingYear":"第12期（自　2019年１月１日　至　2019年12月31日）","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":7136000000.0,"currentAssets":3612000000.0,"fixedAsset":null,"tangibleFixedAssets":44000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":751000000.0,"currentLiabilities":661000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":961000000.0,"capitalSurplus":4630000000.0,"accumulatedEarnings":869000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":43000000.0,"grossProfit":null,"sgaExpenses":391000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-751000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-4000000.0,"cashFlowFromFinancialActivities":-11000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/5\/14","stockCode":4597,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":44035733.0,"sharesOwendPercent":0.3767,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":6130000000.0,"currentAssets":2729000000.0,"fixedAsset":null,"tangibleFixedAssets":41000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":486000000.0,"currentLiabilities":410000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":961000000.0,"capitalSurplus":4630000000.0,"accumulatedEarnings":128000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":64000000.0,"grossProfit":null,"sgaExpenses":724000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1651000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-56000000.0,"cashFlowFromFinancialActivities":-22000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2020\/8\/12","stockCode":4597,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":7926000000.0,"currentAssets":4507000000.0,"fixedAsset":null,"tangibleFixedAssets":38000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":2641000000.0,"currentLiabilities":2542000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":1115000000.0,"capitalSurplus":4769000000.0,"accumulatedEarnings":-536000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":100000000.0,"grossProfit":null,"sgaExpenses":1085000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2243000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-161000000.0,"cashFlowFromFinancialActivities":2521000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/11\/13","stockCode":4597,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":77.0,"averageTemporaryStaff":1.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":44838026.0,"sharesOwendPercent":0.3643,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":5775000000.0,"currentAssets":3269000000.0,"fixedAsset":null,"tangibleFixedAssets":43000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":2123000000.0,"currentLiabilities":2079000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":1402000000.0,"capitalSurplus":5043000000.0,"accumulatedEarnings":-2726000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":209000000.0,"grossProfit":null,"sgaExpenses":2432000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2789000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-171000000.0,"cashFlowFromFinancialActivities":1829000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2021\/3\/29","stockCode":4597,"accountingYear":"第13期（自　2020年１月１日　至　2020年12月31日）","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":5063000000.0,"currentAssets":2609000000.0,"fixedAsset":null,"tangibleFixedAssets":41000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":1149000000.0,"currentLiabilities":1055000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":1861000000.0,"capitalSurplus":5499000000.0,"accumulatedEarnings":-3382000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":41000000.0,"grossProfit":null,"sgaExpenses":434000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-650000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-3000000.0,"cashFlowFromFinancialActivities":-99000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/5\/12","stockCode":4597,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":48016280.0,"sharesOwendPercent":0.3664,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":4476000000.0,"currentAssets":2088000000.0,"fixedAsset":null,"tangibleFixedAssets":39000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":1160000000.0,"currentLiabilities":1079000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":1932000000.0,"capitalSurplus":5569000000.0,"accumulatedEarnings":-4121000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":157000000.0,"grossProfit":null,"sgaExpenses":865000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1222000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-2000000.0,"cashFlowFromFinancialActivities":29000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2021\/8\/11","stockCode":4597,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":3713000000.0,"currentAssets":1345000000.0,"fixedAsset":null,"tangibleFixedAssets":37000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":757000000.0,"currentLiabilities":678000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":2110000000.0,"capitalSurplus":5746000000.0,"accumulatedEarnings":-4837000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":157000000.0,"grossProfit":null,"sgaExpenses":1367000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2049000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-106000000.0,"cashFlowFromFinancialActivities":372000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/11\/10","stockCode":4597,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E33044","endDate":"2021\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":77.0,"averageTemporaryStaff":1.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":45729570.0,"sharesOwendPercent":0.3414,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":3144000000.0,"currentAssets":894000000.0,"fixedAsset":null,"tangibleFixedAssets":36000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":556000000.0,"currentLiabilities":489000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":2110000000.0,"capitalSurplus":5738000000.0,"accumulatedEarnings":-5204000000.0,"treasuryStock":-70000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":185000000.0,"grossProfit":null,"sgaExpenses":1948000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2473000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-164000000.0,"cashFlowFromFinancialActivities":361000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2022\/3\/24","stockCode":4597,"accountingYear":"第14期（自　2021年１月１日　至　2021年12月31日）","accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E33044","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":960,"settlementDate":"2022\/12\/31","submitterName":"ソレイジア・ファーマ株式会社","submitterNameEnglish":null,"submitterNameKana":"ソレイジア　ファーマカブシキカイシャ","location":"港区芝公園二丁目１１番１号","industory":"医薬品","corporateNumber":9010000000000.0}]